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INTRODUCTION:  Asymptomatic  lesions  of the  pancreas,  referred  to as  ‘incidentalomas’,  have  appeared
with  increased  frequency  in recent  years.  Giant  incidentalomas  have  rarely  been  reported  in the  literature.
PRESENTATION  OF  CASE:  We  report  herein  a rare  case  of  a giant  cystic pancreatic  incidentaloma  measuring
12.7  cm  ×  8 cm, which  was  found  in an  otherwise  healthy  male  patient  during  a routine  genitourinary
imaging  work-up.  The  patient  underwent  a distal  pancreatectomy  and  splenectomy;  the  pathology  report
demonstrated  a giant  serous  cystadenoma  of  the  body  and tail  of  the  pancreas.ancreas
ncidentaloma
erous cystadenoma
DISCUSSION: The  management  of  pancreatic  incidentalomas  is challenging.  While  solid  lesions  almost
always  warrant  surgery,  there  is  ongoing  debate  concerning  the  management  of cystic  lesions  that  are
found  incidentally  in the pancreas  and  have  no  clinical  manifestations.
CONCLUSION: We  report  herein  an  interesting  case  of  a voluminous  incidental  cystic  pancreatic  lesion.
The  appropriate  approach  and  the  decision  whether  to  operate  or not  in  such  cases  can  be puzzling  to
the  physician.
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. Introduction
Continuous improvement in imaging resolution during the past
ears has led to increasing reports of incidental lesions. Although
he most prevalent site of such lesions is the adrenal gland, inciden-
alomas can also be located on other organs, such as the kidney,
ituitary, parotid gland, liver, heart, prostate and pancreas. Like
heir symptomatic counterparts, incidental lesions can be solid or
ystic. While solid pancreatic masses, even without any clinical
anifestations, call for surgical management, there is consider-
ble debate regarding the management of cystic asymptomatic
esions found incidentally in the pancreas. We  report herein a case
f an otherwise healthy male individual who was admitted to our
epartment after a giant pancreatic lesion was found incidentally
uring a routine genitourinary ultrasound. We  also review the lit-
rature concerning the ongoing debate on when and whether to
erform surgery for large, cystic pancreatic lesions.
.  Case reportA  74-year-old male was admitted to our Surgical Department for
anagement of a giant asymptomatic pancreatic mass, identiﬁed
n a routine genitourinary ultrasound. The lesion was  hypoechoic,
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well deﬁned, and occupied the body and tail of the pancreas, with-
out any other abnormal ﬁndings. The patient did not mention any
abdominal discomfort or other complaints. He denied any alcohol
consumption and his past medical history was  otherwise unre-
markable. Physical examination of the abdomen was negative for
any palpable mass. Routine serum chemistry proﬁle ranged within
normal levels. His serum CA 19-9, a-fetoprotein and CEA tests were
normal. CT scan of the abdomen revealed a giant tumour mea-
suring 12.7 cm × 8 cm that was  localized to the body and tail of
the pancreas. The lesion was  non-homogeneous and hypodense
compared to normal pancreatic tissue and demonstrated a cystic
component with multiple septa. There was  no dilation of the main
pancreatic duct and no other abnormality such as a hepatic mass or
lymphadenopathy was  detected (Fig. 1a). Abdominal MRI showed
a giant pancreatic lesion composed of numerous small cysts with
ﬁbrous septa between them and a ﬁbrous central scar that was
enhanced on delayed contrast MR  sequences. No visible communi-
cation between the cysts and the pancreatic duct was noted (Fig. 1b
and c).
After a thorough preoperative workout, an exploratory laparo-
tomy conﬁrmed the presence of an enormous, well-circumscribed,
more solid-appearing lesion, occupying the body and tail of the
pancreas. The lesion was  attached to the splenic porta and the
transverse mesocolon, without causing any mesocolon vasculature
Open access under CC BY-NC-ND licensecompromise. The patient underwent an en-block distal pancrea-
tectomy and splenectomy under general endotracheal anaesthesia
(Fig. 2a and b). His postoperative course was  uneventful, and he
was discharged on the 7th postoperative day.
 BY-NC-ND license.
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Fig. 1. (a) Transverse contrast enhanced CT obtained during pancreatic phase
shows  a well-circumscribed encapsulated low-attenuation inhomogeneous tumour
of pancreatic body and tail with internal septa. (b) MRI  T2-weighed coronal image
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lemonstrates very high intensity of the mass with polycystic pattern and multi-
le  ﬁbrous septa. (c) MRI  T1-weighed gadolinium enhance delayed image depicts
nhancement of internal septa and central scar (arrow shows the scar tissue area).
The pathology report revealed a pure serous pancreatic cys-
adenoma. The tumour was grossly well circumscribed. On
ross-section, it was sponge-like and composed of numerous tiny
ysts ﬁlled with serous ﬂuid. The cysts were arranged around a cen-
ral ﬁbrous stellate scar. Histologically, the cysts ranged from 0.01
o 0.5 cm and were lined by a singlelayer of cuboidal epithelial cells.
heir cytoplasm was almost clear, and their nuclei were centrally
ocated, round, uniform and hyperchromatic. Occasionally, theFig. 2. (a) Intraoperative view of an enormous encapsulated tumour mass occupying
the body and tail of the pancreas. The tumour is attached to the splenic porta. (b)
Pancreatic tumour mass resected en-block with the spleen.
neoplastic cells formed intracystic, micro-papillary projections. The
periodic acid-Schiff (PAS) stain was positive, whereas PAS-diastase
was negative due to the presence of abundant intracytoplasmic
glycogen. The neoplastic cells were immunoreactive for epithelial
membrane antigen and cytokeratins 7, 8/18 and 19 owing to the
epithelial nature of this neoplasm (Fig. 3a and b).
3.  Discussion
Incidentally discovered solid organ lesions that cause no symp-
toms (incidentalomas) are increasingly being detected due to
emerging imaging resolution during the past years. Common inci-
dentalomas have been described in the liver, kidney and adrenal
glands.1 There has also been an increase in the occurrence of
unusual, asymptomatic tumours of the pancreas. The ﬁrst report of
pancreatic incidentaloma in the literature was published by Kostiuk
in 2001 (2 cases) and several series have since been reported.2Such incidental pancreatic tumours include serous cystadeno-
mas, mucinous cystadenomas, mucinous cystadenocarcinomas,
nonfunctional neuroendocrine tumours, papillary cystic and solid
tumours, and intraductal papillary mucinous neoplasms (IPMN).1
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Fig. 3. (a) Serous pancreatic cystadenoma – cross-section. Well-circumscribed
tumour  with numerous tiny cysts ﬁlled with serous ﬂuid. Note the central stel-
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date  scar and sponge-like appearance. (b) Hematoxylin & Eosin (H&E) stain (100×
riginal magniﬁcation). Cysts lined by a single layer of cuboidal epithelial cells with
ound, hyperchromatic, uniform nuclei.
ucinous cystic tumours, serous cystadenomas, and intrapapillary
ucinous neoplasia (IPMN) comprise more than 90% of overall pri-
ary cystic neoplasms of the pancreas. Cystic islet cell tumours,
olid pseudopapillary tumours, and other pathologies with cystic
ppearance are less common.3
The management of patients with these ﬁndings in organs, such
s thyroid, adrenal gland, and lung, has been well described, and
reatment algorithms have been proposed. However, literature on
ancreatic incidentalomas is lacking, and given their increased
ncidence, guidelines regarding their management are yet to be
eveloped.4
Multislice contrast-enhanced CT scan is an excellent exam-
nation for the initial detection of pancreatic lesions and for
haracterization through visualization of calciﬁcations, septa, nod-
les and ﬁndings suggestive of pancreatitis. Magnetic resonance
maging (with a combination of rapid T2-weighted sequences and
nenhanced and contrast enhanced T1-weighed sequences) has the
dded advantage of providing better tissue characterization, allow-
ng for the optimal evaluation of the internal architecture of a cyst
nd optimal demonstration of enhancing soft-tissue element.5–7 In
he future, newer techniques including F-18-ﬂuorodeoxyglucose
ositron  emission tomography (FDG-PET) may  help in distinguish-
ng benign and malignant pancreatic incidentalomas.
To date, the existing methods to characterize pancreatic cysts
ack the accuracy to distinguish between low-risk and high-risk
esions. The assessment of the cysts based purely on morphologic
eatures cannot accurately distinguish the type of cyst or pre-
ict malignant transformation.8 Mucinous tumours or macrocysticPEN  ACCESS
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adenomas  may  be either cystadenomas or cystadenocarcinomas.
Mucinous cystadenoma is not a malignant lesion but has the
potential for malignant transformation with rapid progression and
should thus be viewed as premalignant or potentially malignant.
Surgical resection is recommended in patients with appropriate
surgical risk.1 Cystadenocarcinoma is a malignant tumour and
should be treated with aggressive surgical intervention.1 IPMN
is a newly described pancreatic neoplasm deﬁned by the World
Health Organization in 1996. This lesion represents a premalig-
nant or frankly malignant condition with a histologic spectrum
ranging from adenoma to inﬁltrating carcinoma. The proportion
of tumours that are malignant varies from 21% to 37%. Surgical
resection is recommended in all appropriate-risk patients.1 Recent
ﬁndings imply that many incidental pancreatic cysts are small
IPMN-branched duct lesions (IPMN-Br), which have a low potential
for malignancy. Fernandez-del Castillo pointed out that IPMN was
the most frequent type of symptomatic and asymptomatic cysts
and Levy reported that 39% of IPMNs are incidental, 50% of IPMNs
are IPMN-Br, and the risk of developing high-grade dysplasia or
invasive carcinoma within 5 years is 63% for main pancreatic duct
IPMN and 15% for IPMN-Br.9
Lahav suggested that the natural course of incidental pancre-
atic cysts usually is benign after a median follow-up period of 48
months. However, one should be aware that mucinous cystic neo-
plasm is a pathologic diagnosis and it is not clear how many of our
un-operated cysts were mucinous. Data from the Lahav series fails
to agree with other studies that have reported rates of 20–42% of
premalignant or malignant lesions in pancreatic cysts.8
Morphologic features derived from EUS allow the endoscopist
to suggest a diagnosis in about two-thirds of cases.10 In a series by
Ferrone et al. this fact matched the ﬁnal histopathological diagnosis
in 52% of asymptomatic cysts, respectively.10 Cytologic examina-
tion of the cyst contents often is non-diagnostic because of the
inadequacy of the specimen acquired by the aspiration.8 The yield
and sensitivity of aspirate analysis are far from satisfactory, and
in many cases they do not allow for a ﬁnal characterization of the
cyst.8
Patients with incidentally discovered pancreatic lesions and
thought to have a low risk of cancer may  be managed by serial
observation; for example, cystic tumours <2 cm in patients with no
clinical or radiologic features of malignancy.4 In a series by Bruzoni
et al., 80% of patients who  had tumours >2 cm had a malignancy,
indicating that these patients are more likely to need resection,
whereas those with smaller tumours may  simply be monitored. The
Massachusetts General Hospital Group published an algorithm in
2003 to manage patients with incidental pancreatic cysts.4 Accord-
ing to their algorithm patients with cysts <2 cm or those with
cysts >2 cm combined with negative carcinoembryonic antigen
(CEA), mucin, or cytology levels can be observed clinically. The
International Consensus Guidelines for Management of Intraduc-
tal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms
of the Pancreas concluded that patients with cystic lesions >3 cm,
or high malignancy-risk patient with lesions between 1 and 3 cm,
would beneﬁt from resection.4
In our case, the giant pancreatic lesion described herein turned
out to be a serous cystadenoma. Although there is no management
consensus in the pertinent literature regarding large asymptomatic
pancreatic cysts, several authors suggest that such lesions mandate
close observation provided that preoperative diagnosis precludes
mucinous cystic neoplasms or cystadenocarcinoma. However, Stro-
bel suggests that serous cystic neoplasms of the pancreas do have
malignant potential with a risk of malignancy of 3% and should be
surgically treated if the operative risk is acceptable.11 In cases of
non-deﬁnitive diagnosis of incidental pancreatic cysts, given the
safety of pancreatic resection in specialized centers, Lahat et al.
support resection as the treatment of choice.3
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The generally benign course of serous cystic neoplasias has led
o an ‘observational’ trend for many years; however, this policy
as recently been debated. The decrease in perioperative mortality
fter major pancreatectomy during the last two  decades proba-
ly accounts in part for the altered consensus regarding a more
ggressive approach with resection.11,12
In our case, the lesion was very large, measuring 12.7 cm × 8 cm.
here appears to be a current trend towards surgery for serous cys-
ic lesions with a size >4 cm.12 Any presence of symptomatology
r  diagnostic uncertainty equally warrants surgery.12 In our case
resented herein, apart from the large size of the cyst, imaging
ailed to exclude serous malignancy. Upon diagnostic doubt, some
uthors recommended cyst aspiration with ﬂuid analysis; more
ecently, endoscopic ultrasound (EUS) with ﬁne-needle aspiration
FNA) has been suggested as a method to differentiate between
enign, premalignant, and malignant lesions. However, aspiration
ither percutaneously or endoscopically via EUS has signiﬁcant
pillage potential and is therefore not routinely recommended.13,14
ue to the large size of the cyst, spillage risk was signiﬁcant in
ase an FNA was performed. Our patient was a 72 year old, oth-
rwise healthy individual. Spinelli et al. mandate surgical excision
or pancreatic cysts that increase under observation, manifest with
ymptoms or are discovered in healthy, older patients.14 He also
ound that older patients over 70 years are more likely (p < 0.02)
o have premalignant or malignant cystic pancreatic neoplasms.14
erous cystadenoma of the pancreas presents at an earlier age (61
ears) than serous cystadenocarcinoma (66 years; p = 0.056) and
re symptomatic in the majority of patients.11
. Conclusion
A  thorough understanding of the current trend towards asymp-
omatic cystic lesions in the pancreas along with weighing
f individual patient factors are essential to guide a surgical
eam towards the optimal management of such cystic pancre-
tic tumours. In this interesting case, the large size and doubtful
reoperative diagnosis combined with a modern, literature-based
ggressive surgical practice for this type of lesions, led us to opt for
urgery in this, otherwise healthy, 72 year old patient.
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